For developing an improved understanding of the interactions of individual cells within their microenvironment, advanced molecular probing solutions are being used by researchers across the globe. In this context, high-throughput single-cell analysis, has emerged as a powerful analytical technique for studying individual cells, enabling researchers to study gene expression at single cell resolution. Single-cell sequencing techniques enable the detection of complex and rare cell populations, and elucidate the development trajectories of distinct cell lineages. Future advancements in this domain are likely to bring about a paradigm shift in the field of clinical research, and disease diagnosis, progression and treatment. Further, the potential of single-cell RNA sequencing (scRNA-seq) technologies to reveal previously unknown cellular mechanisms, and identify novel biomarkers, such technologies are likely to witness significant adoption in biomedical research over the next decade.
Players Engaged in Offering Single-Cell Sequencing Services
Close to 100 industry and non-industry players claim to offer single-cell sequencing services to consumers across the globe
Geographical Location of Single-cell Sequencing Service Providers
Majority of the industry players engaged in offering single-cell sequencing services are based in developed regions, primarily in North America (72%) and Europe (17%). It is worth noting, that a large number of non-industry players offering single-cell sequencing services are concentrated in the North American region, followed by Europe and Asia-Pacific.
Companies Engaged in Offering Single-cell Sequencing Technologies
In the last few years, several companies have introduced innovative technology platforms for application in single-cell sequencing. Prominent examples of companies offering innovative technology platforms include (in alphabetical order, no selection criteria) 10x Genomics, Becton Dickinson, Fluidigm and Illumina.
More Than 2,300 Academic Grants have been Awarded to Institutions Working in the Single-Cell Sequencing Domain
The last five years have witnessed monumental increase in the number of grants awarded to academic institutions amounting to USD 1.15 billion
Demand for Single-cell Sequencing Services and Technologies is Anticipated to Grow at a CAGR of 15%, During 2020-2030
Owing to the potential applications of single-cell sequencing in drug discovery, diagnostics and other areas of healthcare domain, the single-cell sequencing services and technologies market is likely to grow at an annualized CAGR of 17% over the next decade. Analysis of market opportunity on the basis of application area revealed that majority of the current market share (70%) is held by application of such techniques in drug discovery (early stage research). Further, in terms of geographical distribution North America currently holds 40% market share within the single-cell sequencing market, and is expected to dominate the market in the coming decade.
To get a detailed information on the key players, intellectual property portfolio, academic grant awards, and the likely market evolution.